Table 1.
Pregnancy outcomes among female patients and partners of male patients enrolled in teriflunomide clinical studies
| Pregnancy outcome | Teriflunomide | Placebo | Interferon beta | Total |
|---|---|---|---|---|
| Female patients | ||||
| Live birth | 26 | 2 | 2 | 30 |
| Induced abortion | 29 | 8 | 0 | 37 |
| Spontaneous abortion | 13 | 1 | 0 | 14 |
| Ongoing pregnancy | 1a | 0 | 0 | 1a |
| Unknown | 1 | 0 | 0 | 1 |
| Total | 70 | 11 | 2 | 83 |
| Female partners of male patients | ||||
| Live birth | 16 | 2 | – | 18 |
| Induced abortion | 2 | 1 | – | 3 |
| Spontaneous abortion | 1 | 0 | – | 1 |
| Total | 19 | 3 | – | 22 |
aFollowing data cut-off, the ongoing pregnancy resulted in the delivery of a baby boy at 39 weeks of pregnancy